Background. Recent observations in our country have shown that late diagnosis of chronic renal failure (CRF) is an important cause of late referral and late commencement of maintenance dialysis. We prospectively investigated the influence of late diagnosis of CRF on patient mortality during dialysis therapy.
Introduction
In Sao Paulo, a large number of patients with chronic renal disease are first admitted to health institutions with advanced renal failure. Many of them have little or no predialysis care and present with clinical complications and biochemical abnormalities requiring emergency dialysis [1] . Some studies in Europe and the US have shown that late referral of patients for maintenance dialysis is not uncommon [2] [3] [4] [5] [6] . In developing countries late diagnosis of chronic renal failure (CRF), late referral to nephrology units, and presentation with terminal renal failure are probably more frequent [1, 7] . Retrospective studies have shown that late referral has detrimental consequences such as more severe metabolic disorders and poorer clinical conditions at presentation [3, 6] , and is possibly associated with a higher rate of early dialysis mortality [5, 8] . There are no prospective studies evaluating the impact of late diagnosis on the subsequent outcome of patients on dialysis. The objective of the present study was to investigate prospectively the influence of late diagnosis of CRF on mortality during the first 6 months of maintenance dialysis.
Subjects and methods
From October 1992 to March 1995, 252 new patients started maintenance dialysis for end-stage renal disease (ESRD) at the Nephrology Division, Hospital Sao Paulo, in the city of Sao Paulo. Patients with renal involvement secondary to diabetes mellitus (// = 47) were excluded from the study. Of the remaining 205 patients, 106 had a diagnosis of chronic renal failure that had been made less than 1 month before the start of dialysis (late diagnosis group), and 78 had been diagnosed more than 3 months prior to the start of dialysis (early diagnosis group). Patients whose diagnosis had been made between 1 and 3 months before the start of dialysis (n = 21) were excluded from the analysis.
At the time of admission to the dialysis unit information was collected by one of us (AGB) using a standardized questionnaire that included sociodemographic data, primary diagnosis, time of diagnosis of renal disease, predialysis nephrological care, coexisting diseases, blood pressure meas-urement, laboratory tests, and type of dialysis. Patients on haemodialysis received 12 h dialysis per week using cuprophane membrane dialysers and bicarbonate dialysis solutions. Blood flow rate and dialysate flow rate were 300 ml/min and 500 ml/min respectively. Dialysers were reused by a manual technique and disinfected with formalin. Continuous ambulatory peritoneal dialysis consisted of four exchanges of 2 1 dialysate daily. Patients were prospectively followed up for 6 months after the start of dialysis.
Statistical analysis
The Student / test, the Mann-Whitney test, the chi-square, and the Fisher's exact tests were used as appropriate. Patient survival was estimated by the Kaplan-Meier method. Comparison between survival curves was made by the logrank test. The influence of prognostic factors on the risk of death was assessed using the Cox proportional hazards regression model. The variables tested included time of diagnosis of CRF, age, race, comorbid conditions, blood pressure, serum albumin (measured by a bromocresol green method), and urea concentrations.
Results
Fifty-eight per cent (106/184) of the patients with chronic renal failure were diagnosed less than 1 month prior to the start of maintenance dialysis. Baseline characteristics of patients with late and early diagnosis are shown in Table 1 . In the early diagnosis group, 51 patients (65%) received follow-up care at a nephrology clinic before starting dialysis. In the late diagnosis group the main clinical symptoms at presentation were dyspnoea/pulmonary oedema (41%), severe hypertension (blood pressure > 200/120 mmHg) (26%), severe asthenia (22%) and apathy/mental changes (8%). Patients with a late diagnosis had a greater rate of pulmonary infective episodes and a higher mean systolic blood pressure (Table 1 ). All haemodialysis patients with a late diagnosis used a central venous catheter as the initial dialysis access, while among those with an early diagnosis, 26 had an arteriovenous fistula suitable for use. Laboratory findings before the first dialysis are shown in Table 2 . A measurement of the delivered haemodialysis dose (Kt/V of urea, single pool model) was available for 35 patients after a mean duration of 3 months of treatment. For this subgroup, mean (SE) Kt/V was 0.98 (0.03).
Overall, 41 deaths occurred during the 6 months of follow-up, 31 in the late and 10 in the early diagnosis group. Of these, 28 (68%) occurred during the first 3 months of treatment. The main causes of death in the late diagnosis group were cardiac disease, n = 1, cerebrovascular disease, n=4, infection, « = 9, unknown, n = 6 and others, n = 5. For the early diagnosis group the corresponding figures were 3, 1, 3, 2 and 1. Overall patient survival was 85 and 77% after 3 and 6 months of dialysis therapy respectively. Patient survival rate was significantly lower for the late than the early diagnosis group after 6 months (69% versus 87%, i><0.01) (Figure 1 ). The risk of death was 2.77 (95% confidence interval, 1.36-5.66) times higher for R. Sesso and A. G. Belasco serum albumin were significant and independent predictors of mortality (Table 3) .
Discussion
Sao Paulo is the largest city in South America, with a population of 9.85 million in 1994 and a gross domestic product per capita of US $ 4630. In the metropolitan area in 1994, the incidence rate of dialysis treatment was 97 patients per million population (p.m.p.) and the prevalence rate was 248 p.m.p. [9] . Compared to other countries with similar incidence rates, this relatively low prevalence suggests a reduced life expectancy on dialysis treatment. ESRD therapy is completely financed by the state. The annual cost per patient on haemodialysis is US $ 11 466 (excluding costs with hospitalization for intercurrent illnesses). More than half of the patients in this study had a diagnosis of CRF made less than 1 month before the start of dialysis. The high incidence of patients with a late diagnosis may reflect the characteristics of referral to our university institution, which is one of the main public medical centres in the city, receiving patients from all regions of Greater Sao Paulo, and where any patient is eligible to receive chronic dialysis treatment through a national health insurance programme. Retrospective studies in Europe and the US have suggested that late referral of CRF patients for dialysis and late start of treatment are common [2] [3] [4] [5] [6] . The detrimental consequences of late referral, such as more severe uraemic disorders and poorer clinical conditions at presentation, have been reported [1, 3, 5, 6] . Nonetheless, this is the first prospective study focusing specifically on the outcome of patients with a late diagnosis of CRF. Our results clearly show the negative impact of late diagnosis on survival of dialysis patients. Late diagnosis and start of the dialysis programme seem to be important features of ESRD treatment in developing countries. As a matter of fact, developing nations have devoted only a small proportion of their gross national product to health. A correlation between the prevalence of treated ESRD and the per capita income has been reported [10] . The acceptance and prevalence rates of renal replacement therapy in developing nations are lower than those in North America and in Europe [7, [10] [11] [12] [13] . Recently we reported that in Sao Paulo more than a quarter of patients with CRF died without being accepted for dialysis [11] . In developing nations, in addition to the insufficient number of dialysis places, there is a shortage of essential equipment and reagents, the dialysis machines in use are obsolete, and the common practice of reusing dialysers and blood tubing should follow more rigid recommendations. Low salaries are paid to health care personnel and, as a result, less qualified and poorly motivated individuals are working in the units [7] .
In the present study the overall probability of survival was 85% and 77% at 3 and 6 months respectively. The reasons for this high mortality are probably related to the poor clinical conditions of the patients at the beginning of the dialysis programme and the association with comorbid factors. The findings of malnutrition, infective episodes, pulmonary oedema, and severe hypertension were common, especially among those with a late diagnosis of CRF. It seems also possible that inadequacy of dialysis contributed to the high mortality. The dosage of delivered dialysis was not closely monitored during this period and only a small percentage of the patients had a Kt/V measurement available. The mean Kt/V value for these patients suggests that the delivered dialysis was suboptimal.
The 6-month survival rate of late diagnosis patients was 18% lower than that of early diagnosis patients. In the late diagnosis group, mortality risk was 2.8 times that of the early diagnosis group. To further explore the association between time of diagnosis and mortality risk we used a multivariate survival analysis. None of the previously published reports used this type of approach. We observed that the increased risk of death was associated with other non-renal comorbid R. Sesso and A. G. Belasco conditions present at the beginning of treatment, since after adjusting for a number of risk factors, the effect of late diagnosis did not remain significant. The variables found to be significant predictors of early mortality were older age, presence of pulmonary infection, and low serum albumin concentrations.
The absence or scarcity of symptoms until patients have reached ESRD may be one of the reasons for late diagnosis. More importantly, it seems that our health care system has failed to detect cases of renal impairment at an earlier stage and to provide adequate follow-up for them. Although the entire population of Brazil is covered for health insurance, the medical assistance provided by public services is insufficient and of poor quality. In Brazil, as in many other countries, the health care system needs to be restructured to improve the access to primary care physicians, and the surveillance and control of patients at risk of developing ESRD.
In conclusion, this study shows that a large percentage of patients had a late diagnosis of CRF and that these patients had a higher mortality risk during the first 6 months of dialysis. Interventions to promote early diagnosis and adequate predialysis follow-up need to be evaluated since they appear to be important in improving the survival of CRF patients.
